CMV as an Exacerbating Agent in Transplant Vascular Sclerosis: Potential Immune-Mediated Mechanisms Modelled In Vitro

Author： Waldman W.J. Adams P.W. Knight D.A. Sedmak D.D.

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.29, Iss.1, 1997-02, pp. : 1545-1546

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transplant Vascular Sclerosis Symposium Series

By Hutchinson I.V.

Transplant Immunology, Vol. 5, Iss. 3, 1997-09 ,pp. : 167-167

Elsevier

Access to resources Recommend Favorite

Genetic therapy for transplant vascular sclerosis

By Bennett C.F. Stepkowski S.M.

Transplant Immunology, Vol. 5, Iss. 4, 1997-12 ,pp. : 299-302

Elsevier

Access to resources Recommend Favorite

Contribution of lipids to the pathogenesis of transplant vascular sclerosis

By Wilson J.E. Wood S. McDonald P. Kenyon J. Dong C. McManus B.M.

Transplant Immunology, Vol. 5, Iss. 4, 1997-12 ,pp. : 247-250

Elsevier

Access to resources Recommend Favorite

Role of the antibody in the pathogenesis of transplant vascular sclerosis: a hypothesis

By Wewers M.D. Marsh C.B.

Transplant Immunology, Vol. 5, Iss. 4, 1997-12 ,pp. : 283-288

Elsevier

Access to resources Recommend Favorite

Evaluation of a Lymph Node Proliferation Assay for its Ability to Detect Pharmaceuticals with Potential to Cause Immune-Mediated Drug Reactions

By Weaver James Chapdelaine Joan Descotes Jacques Germolec Dori Holsapple Mike House Robert Lebrec Herve Meade Jean Pieters Raymond Hastings Kenneth Dean Jack

Journal of Immunotoxicology, Vol. 2, Iss. 1, 2005-01 ,pp. : 11-20

Informa Healthcare

Access to resources Recommend Favorite